Forward Pharma is ...

Forward Pharma is a privately held biotechnology company focused on developing novel and improved immunomodulatory compounds for the treatment of psoriasis and other autoimmune and inflammatory disorders.

Our lead drug candidate, FP 187, is currently undergoing Phase II testing in 18 centers in Germany and is foreseen to include at least 180 patients with moderate to severe plaque psoriasis.

 

Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark, in the heart of Medicon Valley. Since 2007 we are also operating out of a subsidiary, Forward Pharma GmbH, in Leipzig, Germany